Aidoc is the better overall radiology AI platform with the widest algorithm portfolio (30+ FDA-cleared). Viz.ai is the leader for acute care detection, particularly stroke, with proven outcomes data and care team coordination across 1600+ hospitals. Many health systems deploy both for complementary coverage.
Key Takeaways
- This is the most important comparison in radiology AI, with both being market leaders
- Aidoc provides the broadest AI coverage across pathologies and modalities
- Viz.ai leads in stroke detection and care coordination with 1600+ hospital deployments
- Many large health systems deploy both: Aidoc for broad triage, Viz.ai for stroke coordination
- The choice depends on whether breadth (Aidoc) or acute care depth (Viz.ai) matters more
Aidoc wins
Aidoc wins for overall radiology AI breadth, but Viz.ai is the leader for stroke and acute care coordination.
Feature Comparison
| Feature | Aidoc | Viz.ai | Winner |
|---|---|---|---|
| Algorithm Breadth | 30+ FDA-cleared across body regions | Stroke, PE, aortic, and expanding | Aidoc |
| Stroke Detection | Included in algorithm suite | Industry-leading with proven outcomes | Viz.ai |
| Care Coordination | Triage and worklist alerts | Full care team coordination platform | Viz.ai |
| Hospital Deployment | Hundreds of hospitals | 1600+ hospitals | Viz.ai |
| Modality Coverage | CT, X-ray, MRI, and more | Primarily CT-focused | Aidoc |
| Outcomes Data | Growing outcomes evidence | Published stroke outcome improvements | Viz.ai |
Aidoc
Best for: Radiology departments wanting the broadest possible AI detection and triage across specialties
Strengths
- +30+ FDA-cleared algorithms across body regions
- +Broadest pathology coverage in market
- +Always-on worklist triage
- +Strong multi-modality support
Limitations
- -Stroke detection less specialized than Viz.ai
- -Care coordination less developed
- -Less published outcomes data than Viz.ai for specific pathologies
Viz.ai
Best for: Stroke centers, trauma hospitals, and health systems prioritizing acute care detection and care coordination
Strengths
- +Industry-leading stroke detection
- +1600+ hospital deployments
- +Care team coordination platform
- +Published outcome improvements
Limitations
- -Narrower algorithm portfolio than Aidoc
- -Primarily CT-focused
- -Premium enterprise pricing
Detailed Analysis
Algorithm BreadthAidoc
Aidoc's 30+ algorithms cover significantly more pathologies than Viz.ai. For departments wanting comprehensive AI support across body regions, Aidoc provides more coverage.
Acute Care ImpactViz.ai
Viz.ai's stroke detection and care coordination platform has proven clinical outcomes, reducing door-to-treatment times. Its care team alert system goes beyond radiology to coordinate entire stroke teams.
Market AdoptionViz.ai
Viz.ai's 1600+ hospital deployments demonstrate wider adoption, particularly in acute care settings. Aidoc has hundreds of deployments with broader but less concentrated penetration.
Radiology WorkflowAidoc
Aidoc's always-on triage better integrates into general radiology workflow by reprioritizing worklists across all pathologies, not just acute cases.
Bottom Line
For comprehensive radiology AI, deploy Aidoc for broad detection and triage. For stroke centers and acute care hospitals, Viz.ai is essential for its care coordination and proven outcomes. Large health systems should seriously consider deploying both for complete coverage. If budget forces a single choice, Aidoc provides more breadth while Viz.ai provides more depth in acute care.
Frequently Asked Questions
Can I deploy both Aidoc and Viz.ai?
Yes. Many large health systems use both. Aidoc provides broad triage across pathologies while Viz.ai provides deep stroke and acute care coordination. They complement each other well.
Which reduces time-to-treatment more?
Viz.ai has stronger published evidence for reducing time-to-treatment in stroke cases specifically, due to its care team coordination. Aidoc's triage improves time-to-read across all pathologies.
Which is better for PE detection?
Both offer PE detection. Viz.ai has been expanding its PE capabilities with care coordination features. Aidoc includes PE in its algorithm suite. Evaluate both for your specific PE workflow.
Is Viz.ai expanding beyond stroke?
Yes. Viz.ai has expanded into PE, aortic, and other acute pathologies. However, its algorithm breadth still trails Aidoc's 30+ FDA-cleared offerings.
Which is more cost-effective?
Both use enterprise subscription pricing. Aidoc may provide more value per dollar through broader coverage. Viz.ai's value concentrates in acute care where outcomes improvements can justify premium pricing.